The ACTS Intervention to Reduce Breast Cancer Treatment Disparity
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Female
Breast Cancer
Female
Breast Cancer
Trial Information
The ACTS Intervention to Reduce Breast Cancer Treatment Disparity
Inclusion Criteria:
- African American, as determined by patient self report on their demographic form
completed at first medical oncology visit
- Female
- Age 18 or older
- Diagnosed with invasive breast cancer
- Recommended (prescribed) chemotherapy by participating medical oncologists
Exclusion Criteria:
- Impaired cognition, as determined by a score of less than 22 on the Mini Mental
Status Exam
- An inability to understand English
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Adherence to recommended breast cancer chemotherapy
Outcome Time Frame:
midpoint (6 or 12 weeks) and endpoint (12 or 24 weeks) of recommended chemotherapy regimen
Safety Issue:
No
Principal Investigator
Margaret Q Rosenzweig, PhD, FNP-BC, AOCNP
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of Pittsburgh
Authority:
United States: Institutional Review Board
Study ID:
706367
NCT ID:
NCT01184066
Start Date:
January 2010
Completion Date:
Related Keywords:
- Breast Cancer
- Chemotherapy
- Patient Adherence
- African Americans
- Cancer Survivor
- Decision Making
- Communication
- Quality of Life
- Social Support
- Patient Education
- Breast Neoplasms
Name | Location |
|---|---|
| University of Pittsburgh | Pittsburgh, Pennsylvania 15261 |
| West Penn Allegheny Health System | Pittsburgh, Pennsylvania 15224 |
